Last $7.49 USD
Change Today +0.53 / 7.61%
Volume 600.0
RXDX On Other Exchanges
Symbol
Exchange
NASDAQ CM
Stuttgart
As of 9:46 AM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

V. Michael Holers M.D.

Former Scientific Advisor, Ignyta, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

----

Background*

Dr. V. Michael Holers MD, Mike Co-Founded Taligen Therapeutics, Inc. in 2004 and served as its Chief Scientific Officer. Dr. Holers is one of the world's leading experts in complement biology and has published more than 175 articles in the area. His research has focused on the role of complement in initiating inflammation and on the development of novel approaches to controlling complement activation in vivo. Dr. Holers is the Smyth Professor and Chairman of the Division ...

Read Full Background

Corporate Headquarters*

11095 Flintkote Avenue
San Diego, California 92121

United States

Phone: 858-255-5959
Fax: --

Board Members Memberships*

Co-Founder

Education*

Post-Doctoral Training
Washington University, St. Louis
MD
Washington University, St. Louis

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RXDX:US $7.49 USD +0.53

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IGNYTA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.